Electromed (NYSE:ELMD) Upgraded at StockNews.com

StockNews.com upgraded shares of Electromed (NYSE:ELMD) from a buy rating to a strong-buy rating in a report released on Tuesday.

Electromed Price Performance

Shares of ELMD opened at $33.21 on Tuesday. Electromed has a one year low of $11.15 and a one year high of $35.56. The firm has a market capitalization of $280.96 million, a P/E ratio of 46.13 and a beta of 0.33. The business has a fifty day moving average of $31.18 and a 200 day moving average of $24.61.

Electromed (NYSE:ELMD) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.13. Electromed had a return on equity of 15.32% and a net margin of 11.34%. The business had revenue of $14.67 million during the quarter.

Insider Buying and Selling at Electromed

In other news, Director Andrew Summers sold 12,731 shares of the company’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $29.98, for a total value of $381,675.38. Following the completion of the transaction, the director now owns 165,755 shares of the company’s stock, valued at $4,969,334.90. This represents a 7.13 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 14.00% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Electromed

A number of hedge funds have recently made changes to their positions in ELMD. Ritholtz Wealth Management bought a new stake in shares of Electromed in the 4th quarter valued at approximately $488,000. Barclays PLC purchased a new position in shares of Electromed in the 3rd quarter valued at $215,000. Navellier & Associates Inc. purchased a new position in Electromed during the 3rd quarter worth $368,000. State Street Corp grew its stake in Electromed by 14.5% during the 3rd quarter. State Street Corp now owns 22,066 shares of the company’s stock worth $474,000 after buying an additional 2,800 shares during the last quarter. Finally, Walleye Capital LLC purchased a new position in Electromed during the 3rd quarter worth $274,000. 40.82% of the stock is currently owned by hedge funds and other institutional investors.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.